Malignant transformation of CD4+ T lymphocytes mediated by oncogenic kinase NPM/ALK recapitulates IL-2-induced cell signaling and gene expression reprogramming

作者: Michal Marzec , Krzysztof Halasa , Xiaobin Liu , Hong Y. Wang , Mangeng Cheng

DOI: 10.4049/JIMMUNOL.1300744

关键词: STAT5Anaplastic lymphoma kinaseT cellCell activationIL-2 receptorMolecular biologyBiologyCancer researchALK inhibitorRegulation of gene expressionSOCS3

摘要: Anaplastic lymphoma kinase (ALK), physiologically expressed only by nervous system cells, displays a remarkable capacity to transform CD4(+) T lymphocytes and other types of nonneural cells. In this study, we report that activity nucleophosmin (NPM)/ALK chimeric protein, the dominant form ALK in cell lymphomas (TCLs), closely resembles activation induced IL-2, key cytokine supporting growth survival normal lymphocytes. Direct comparison gene expression ALK(+) TCL cells treated with an inhibitor IL-2-dependent ALK(-) stimulated revealed very similar, albeit inverse, gene-regulation pattern. Depending on analysis method, up 67% affected genes were modulated common NPM/ALK IL-2. Based patterns, Jak/STAT- IL-2-signaling pathways topped list identified as both IL-2 NPM/ALK. The dependence five selected genes-CD25 (IL-2Rα), Egr-1, Fosl-1, SOCS3, Irf-4-was confirmed at protein level. IL-2-stimulated CD25, Irf-4 activated predominantly STAT5 STAT3 transcription factors, whereas Egr-1 Fosl-1 was MEK-ERK pathway. Finally, found not associated previously either or ALK, contributes proliferation. These findings indicate transforms target lymphocytes, least part, using pre-existing, signaling pathways.

参考文章(47)
Tomasz Skorski, Artur Slupianek, Mariusz A. Wasik, Liquan Xue, Stephan W. Morris, Puthiyaveettil N. Raghunath, Malgorzata Nieborowska-Skorska, Grazyna Hoser, Qian Zhang, Role of Signal Transducer and Activator of Transcription 5 in Nucleophosmin/ Anaplastic Lymphoma Kinase-mediated Malignant Transformation of Lymphoid Cells Cancer Research. ,vol. 61, pp. 6517- 6523 ,(2001)
Martin U. Kuefer, A. Thomas Look, Karen Pulford, Frederick G. Behm, Paul K. Pattengale, David Y. Mason, Stephan W. Morris, Retrovirus-Mediated Gene Transfer of NPM-ALK Causes Lymphoid Malignancy in Mice Blood. ,vol. 90, pp. 2901- 2910 ,(1997) , 10.1182/BLOOD.V90.8.2901
Patrick T. Walsh, Jidong Zhang, Martin Carroll, Ramon Parsons, Jeffrey C. Rathmell, Craig B. Thompson, Matthew A. Burchill, Michael A. Farrar, Laurence A. Turka, Steven J. Bensinger, Distinct IL-2 Receptor Signaling Pattern in CD4+CD25 + Regulatory T Cells Journal of Immunology. ,vol. 172, pp. 5287- 5296 ,(2004) , 10.4049/JIMMUNOL.172.9.5287
Qian Zhang, Hong Y Wang, Xiaobin Liu, Mariusz A Wasik, STAT5A is epigenetically silenced by the tyrosine kinase NPM1-ALK and acts as a tumor suppressor by reciprocally inhibiting NPM1-ALK expression Nature Medicine. ,vol. 13, pp. 1341- 1348 ,(2007) , 10.1038/NM1659
J. Fujimoto, M. Shiota, T. Iwahara, N. Seki, H. Satoh, S. Mori, T. Yamamoto, Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5). Proceedings of the National Academy of Sciences of the United States of America. ,vol. 93, pp. 4181- 4186 ,(1996) , 10.1073/PNAS.93.9.4181
Yu-Xin Cui, Alan Kerby, Fiona Kate Elizabeth McDuff, Hongtao Ye, Suzanne Dawn Turner, None, NPM-ALK inhibits the p53 tumor suppressor pathway in an MDM2 and JNK-dependent manner. Blood. ,vol. 113, pp. 5217- 5227 ,(2009) , 10.1182/BLOOD-2008-06-160168
Carlo Gambacorti-Passerini, Cristina Messa, Enrico M. Pogliani, Crizotinib in Anaplastic Large-Cell Lymphoma The New England Journal of Medicine. ,vol. 364, pp. 775- 776 ,(2011) , 10.1056/NEJMC1013224
K. Smith, Interleukin-2: inception, impact, and implications Science. ,vol. 240, pp. 1169- 1176 ,(1988) , 10.1126/SCIENCE.3131876